We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COTY icon
501
Coty
COTY
$2.4B
$572K 0.04%
+104,600
New +$655K
SWI
502
DELISTED
SolarWinds Corporation Common Stock
SWI
$569K 0.04%
30,849
ACVA icon
503
ACV Auctions
ACVA
$1.41B
$567K 0.04%
40,210
-29,070
-42% -$535K
ORLA
504
Orla Mining
ORLA
$3.36B
$564K 0.04%
60,340
SENEA icon
505
Seneca Foods Class A
SENEA
$1.15B
$553K 0.04%
6,216
+44
+0.7% +$3.52K
BLZE icon
506
Backblaze
BLZE
$683M
$550K 0.04%
113,848
+70,688
+164% +$435K
TPB icon
507
Turning Point Brands
TPB
$1.48B
$549K 0.04%
+9,232
New +$572K
CNQ icon
508
Canadian Natural Resources
CNQ
$96.9B
$548K 0.04%
+17,800
New +$540K
OFIX icon
509
Orthofix Medical
OFIX
$492M
$548K 0.04%
+33,603
New +$590K
SRAD icon
510
Sportradar
SRAD
$4.42B
$544K 0.04%
+25,177
New +$525K
CAAP icon
511
Corporacion America
CAAP
$4.17B
$544K 0.04%
29,732
-1,130
-4% -$21.3K
BBT
512
Beacon Financial Corp
BBT
$2.5B
$540K 0.04%
20,689
-11,637
-36% -$325K
BPMC
513
DELISTED
Blueprint Medicines
BPMC
$540K 0.04%
6,098
+3,000
+97% +$293K
SITE icon
514
SiteOne Landscape Supply
SITE
$4.16B
$540K 0.04%
4,443
-3,914
-47% -$519K
OPY icon
515
Oppenheimer Holdings
OPY
$1.18B
$540K 0.04%
9,048
-30
-0.3% -$1.94K
MCS icon
516
Marcus Corp
MCS
$767M
$539K 0.04%
32,315
+18,863
+140% +$364K
CTKB icon
517
Cytek Biosciences
CTKB
$566M
$538K 0.04%
+134,065
New +$695K
SGHC icon
518
SGHC Ltd
SGHC
$7.57B
$531K 0.04%
82,425
+43,928
+114% +$315K
BE icon
519
Bloom Energy
BE
$46.6B
$527K 0.04%
+26,800
New +$640K
TENB icon
520
Tenable Holdings
TENB
$3.47B
$526K 0.04%
+15,036
New +$589K
GCMG icon
521
GCM Grosvenor
GCMG
$737M
$525K 0.04%
39,703
CMRE icon
522
Costamare
CMRE
$1.85B
$524K 0.04%
53,242
-28,178
-35% -$311K
TIPT icon
523
Tiptree Inc
TIPT
$694M
$523K 0.04%
21,694
+2,263
+12% +$48.1K
TWFG
524
TWFG Inc
TWFG
$370M
$522K 0.04%
16,887
+692
+4% +$20.8K
GWW icon
525
W.W. Grainger
GWW
$64.2B
$511K 0.04%
517
-1,433
-73% -$1.48M

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.